SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013289
Filing Date
2023-08-04
Accepted
2023-08-03 19:37:07
Documents
84
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ntra-20230630x10q.htm   iXBRL 10-Q 2383226
2 EX-10.1 ntra-20230630xex10d1.htm EX-10.1 55784
3 EX-10.2 ntra-20230630xex10d2.htm EX-10.2 25836
4 EX-31.1 ntra-20230630xex31d1.htm EX-31.1 13831
5 EX-31.2 ntra-20230630xex31d2.htm EX-31.2 14893
6 EX-32.1 ntra-20230630xex32d1.htm EX-32.1 10373
7 EX-32.2 ntra-20230630xex32d2.htm EX-32.2 10656
  Complete submission text file 0001558370-23-013289.txt   11034958

Data Files

Seq Description Document Type Size
8 EX-101.SCH ntra-20230630.xsd EX-101.SCH 58688
9 EX-101.CAL ntra-20230630_cal.xml EX-101.CAL 61256
10 EX-101.DEF ntra-20230630_def.xml EX-101.DEF 317731
11 EX-101.LAB ntra-20230630_lab.xml EX-101.LAB 577711
12 EX-101.PRE ntra-20230630_pre.xml EX-101.PRE 473121
78 EXTRACTED XBRL INSTANCE DOCUMENT ntra-20230630x10q_htm.xml XML 2275588
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

IRS No.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37478 | Film No.: 231141788
SIC: 8071 Services-Medical Laboratories